Asthma: Phenotyping EXacerbations
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Asthma: Phenotyping Exacerbations 2
- Status
- UNKNOWN
- Phase
- N/A
Durvalumab (MEDI4736) Plus Total Neoadjuvant Therapy (TNT) in Locally Advanced Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease.
- Status
- WITHDRAWN
- Phase
- PHASE3
Assess the Safety of Immunotherapy Induction With Tremelimumab and Durvalumab Prior to Chemoradiotherapy and/or Resection in the Treatment
- Status
- TERMINATED
- Phase
- PHASE1
Open-label Extension Study of Brazikumab in Ulcerative Colitis
- Status
- TERMINATED
- Phase
- PHASE2
ChAracterisation of ItaliaN Severe Uncontrolled Asthmatic patieNts Key Features When Receiving Benralizumab
- Status
- COMPLETED
- Phase
- N/A
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD2373 After Single Dose Administration in Healthy Male Subjects of African Ancestry.
- Status
- COMPLETED
- Phase
- PHASE1
A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA Methylation
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase 2 Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTION
- Status
- WITHDRAWN
- Phase
- PHASE2
Acalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Assess the Effect of Verinurad on the Electric Activity of the Heart
- Status
- COMPLETED
- Phase
- PHASE1
Study of Durvalumab Following Radiation Therapy in Patients With Stage 3 Unresectable NSCLC Ineligible for Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
TURKish Acute Myocardial Infarction Registry
- Status
- UNKNOWN
- Phase
- N/A
A Study to Evaluate the Effectiveness and Tolerability of a Second Maintenance Treatment in Participants With Ovarian Cancer, Who Have Previously Received Polyadenosine 5'Diphosphoribose [Poly (ADP Ribose)] Polymerase Inhibitor (PARPi) Treatment.
- Status
- WITHDRAWN
- Phase
- PHASE2
Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Investigating Safety, Tolerability, Efficacy and PK of Olaparib in Paediatric Patients With Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Effect AZD4831 in Japanese and Chinese Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1